Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer’s Disease

Alzheimer’s disease (AD) is the leading cause of dementia that has remained a major medical, sociocultural and economical challenge globally. Previously developed treatments like anticholinesterase inhibitors (AChEIs) and N-methyl-D-aspartate receptor (NMDAR) antagonists only provide short-term symp...

Descripción completa

Detalles Bibliográficos
Autores principales: Abyadeh, Morteza, Gupta, Vivek, Gupta, Veer, Chitranshi, Nitin, Wu, Yunqi, Amirkhani, Ardeshir, Meyfour, Anna, Sheriff, Samran, Shen, Ting, Dhiman, Kunal, Salekdeh, Ghasem H., Haynes, Paul A., Graham, Stuart L., Mirzaei, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612603/
https://www.ncbi.nlm.nih.gov/pubmed/34881080
http://dx.doi.org/10.14336/AD.2021.0719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612603/
https://www.ncbi.nlm.nih.gov/pubmed/34881080
http://dx.doi.org/10.14336/AD.2021.0719

Ejemplares similares